Showing results (411-420 of 5,340) with videos related to

Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|February 11, 2017
Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: a nationwide survey in JapanShinya Suzuki, Rick Abbott, Hiroomi Sakurai, et al.
Japanese Journal of Clinical Oncology|February 8, 2017
Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcomaAkira Kawai, Nobuhito Araki, Yoichi Naito, et al.
Japanese Journal of Clinical Oncology|February 8, 2017
UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecanTomoko Yoshihama, Akira Hirasawa, Hiroyuki Nomura, et al.
Japanese Journal of Clinical Oncology|February 8, 2017
Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumabRyota Tanaka, Yasuhiro Fujisawa, Inoue Sae, et al.
Japanese Journal of Clinical Oncology|February 4, 2017
Recovery from anemia and leukocytopenia after abstinence in Japanese alcoholic men and their genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2Akira Yokoyama, Philip J Brooks, Tetsuji Yokoyama, et al.
Japanese Journal of Clinical Oncology|January 20, 2017
Impact of microscopic orbital periosteum invasion in orbital preservation surgeryKenya Kobayashi, Taisuke Mori, Fumihiko Matsumoto, et al.
Japanese Journal of Clinical Oncology|January 27, 2017
Clinical outcomes of stereotactic ablative radiotherapy in patients with pulmonary metastasisBum-Sup Jang, Hak Jae Kim, Byoung Hyuck Kim, et al.
Japanese Journal of Clinical Oncology|September 1, 1989
Cytotoxic activity of various LAK cells against autologous lung cancer, K-562 and Daudi cellsH Kimura, Y Yamaguchi
Japanese Journal of Clinical Oncology|September 1, 1989
Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patientsN Ohuchi, K Takahashi, N Matoba, et al.
Japanese Journal of Clinical Oncology|February 9, 2017
Long-term survivors of primary central nervous system lymphomaRyuya Yamanaka, Ken Morii, Masakazu Sano, et al.
Pageof 534